Skip to content
Search

Latest Stories

Hub and spoke changes will not come into effect as scheduled

Hub and spoke changes will not come into effect as scheduled

“If pharmacies are to be able to benefit from the hub and spoke arrangements, new clinical services must be commissioned”- says CCA 

The Department of Health and Social Care (DHSC) has notified Community Pharmacy England (CPE) that they will no longer be able to implement the new hub and spoke models from 1 January 2025 as initially planned.

The delay comes after the General Election, which put the progress of these amendments on hold.


The DHSC is currently briefing new ministers across all policy areas, including hub and spoke dispensing between different pharmacy owners.

As this process will take time, the implementation will not proceed as originally scheduled.

CPE has stated that it does not yet have a clear timeline and will provide an update to the sector once more information becomes available.

Malcolm Harrison, CEO of the Company Chemists’ Association (CCA), expressed disappointment over the continued delays in fulfilling commitments made in the 2019 contractual framework agreement to support pharmacies.

He said: “As part of the 2019 five-year deal, community pharmacy has had to make substantial efficiency savings.  In exchange, the Department for Health and NHS England committed to enable more efficient operating models with changes to supervision and hub and spoke laws.”

Harrison highlighted that for pharmacies to be able to benefit from the hub and spoke arrangements, it is essential to commission new clinical services.

“The costs of establishing and maintaining hub operations are significant, and with little to no profit available in dispensing NHS medicines, it is hard to see how new facilities could be established, or pharmacies could afford to procure assembly services from them.

Ultimately, policymakers must realise that community pharmacy needs a ‘new deal’ – one that involves an increase in core funding and investment in new clinical services, such as Pharmacy First,” he added.

In 2022, the DHSC launched a consultation on the hub and spoke dispensing, proposing legislative changes to enable this practice across different legal entities.

The consultation outlined two potential models: Model 1, where patients would interact only with the spoke pharmacy, and Model 2, which would allow the hub to dispense medicines directly to patients on behalf of the spoke pharmacy.

In May 2024, the government confirmed the next steps following the consultation, announcing that the proposed legislative amendments would come into force on 1 January 2025, subject to the approval of the statutory instrument by the Houses of Parliament and the Northern Ireland Assembly.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less